Mayor Michael R. Bloomberg, NYCEDC President Seth W. Pinsky, New York State Senator Martin Golden and SUNY Downstate President Dr. John C. LaRosa announced yesterday the start of development of BioBAT, a 486,000-square-foot center for commercial bioscience at the Brooklyn Army Terminal. The design of BioBAT - a partnership between New York City and SUNY Downstate Medical Center - is now underway. View new renderings or read press release.
The
Brooklyn Army Terminal is a 97-acre, Cass Gilbert-designed facility
on the Brooklyn waterfront, owned by New York City and managed by
NYCEDC. The 4 million square foot Brooklyn Army Terminal is already home
to IAVI, which developed and
occupied 36,000 square feet of lab space.
"The development of BioBAT is an important step in the evolution of the biotech industry in New York City," said NYCEDC President Seth Pinsky. "The addition of nearly 500,000 square feet of commercial lab space on the Brooklyn waterfront means that more of the talented scientists and researchers coming out of our academic institutions can develop their innovations here and create good jobs."
Learn more about New York City’s thriving bioscience industry at the NYCEDC's bioscience page.
